Skip to main content
AUTL $1.14 -2.56%
AUTL logo
AUTL · Autolus Therapeutics plc
Track AUTL — free
$1.14 -0.03 (-2.56%) At close · Nov 16 Play latest call Q1 2026 earnings call transcript
Market Cap
$303.43M
Shares
266.16M
Volume · Nov 16 2.35M Avg daily vol (3M) 2.13M
All webcasts

Earnings call · FY2026 Q2

Autolus Therapeutics plc (AUTL) Q2 2026 Earnings Call

Concluded Aug 11, 2026
Aug 11, 2026
Period
FY2026 Q2
Runtime
—
Sources
3 artifacts
Revenue $45.69M +118.4% YoY
Diluted EPS -$0.15
Gross margin · derived Q4 55.2% +72.0 pp YoY
Net income -$39.11M
Open full screen Slides 35 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.

Forward guidance

1 guided metrics

Management's latest ranges and targets are included below.

Research coverage

3 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed Aug 11, 2026.

Metric Guided
AUCATZYL net product revenue Raised
full year 2026
$140M – $150M

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product$45.67M +118.3% YoY
License$17,000
Full-screen source Call document